首页> 外文OA文献 >Exacerbations in Patients with Chronic Obstructive Pulmonary Disease Treated with Nebulized Glycopyrrolate versus Other Long-Acting Muscarinic Antagonists: A U.S. Healthcare Administrative Database Analysis

【2h】

Exacerbations in Patients with Chronic Obstructive Pulmonary Disease Treated with Nebulized Glycopyrrolate versus Other Long-Acting Muscarinic Antagonists: A U.S. Healthcare Administrative Database Analysis

机译：用雾化甘丙酸酯处理的慢性阻塞性肺病患者的恶化与其他长效的毒蕈碱拮抗剂：A U.S. Healthcare行政数据库分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
J. Wang; X. Niu; S. Sharma; R. Chandra; G. Nagle; W. McMahon;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease [J] . Pleasants Roy A. II The annals of pharmacotherapy . 2019,第3期

机译：甘丙哒晶吡咯/ eflow cs：第一个雾化的长效毒蕈碱拮抗剂批准治疗慢性阻塞性肺病
2. Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers [J] . David Singer, Lindsay GS Bengtson, Caitlin Elliott, International Journal of Chronic Obstructive Pulmonary Disease . 2020,第1期

机译：医疗保健资源利用率，慢性阻塞性肺病患者的慢性阻塞性肺病患者中的再服用，用软雾与干粉吸入器
3. Cost Effectiveness of the Long-Acting P2-Adrenergic Agonist (L ABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LAB A/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal [J] . M. Reza Maleki-Yazdi, Mathieu Molimard, Dorothy L. Keininger, Applied health economics and health policy . 2016,第5期

机译：长效P2-肾上腺素激动剂（L ABA）/长效毒蕈碱拮抗药双重支气管扩张药Indacaterol / Glycopyrronium与LAB A /吸入糖皮质激素联合沙美特罗/氟替卡松在慢性阻塞性肺部疾病患者中的成本效益比较：分析法国，意大利和葡萄牙
4. The patternof patients with frequent acute exacerbations of chronic obstructive pulmonary disease (AECOPD) [C] . Grzetic-Romcevic T., Sonc S., Devcic B. World Congress on Immunopathology Respiratory Allergy . 2012

机译：慢性阻塞性肺疾病频繁急性加剧的患者模式（COPD）
5. Providing ethical care: Cardiopulmonary Resuscitation (CPR) for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Patients with End Stage Lung Disease (ESLD). [D] . Young, Jeanne. 2010

机译：提供伦理护理：心肺复苏术（CPR）用于终末期肺病（ESLD）患者的慢性阻塞性肺疾病（COPD）加重。
6. Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease [O] . Roy A. Pleasants II -1

机译：格隆溴铵/ eFlow CS：首个雾化的长效毒蕈碱拮抗剂被批准用于治疗慢性阻塞性肺疾病
7. Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease [O] . Roy A. Pleasants 2018

机译：甘丙吡咯醇/ eflow cs：第一个雾化长效毒蕈碱拮抗剂批准治疗慢性阻塞性肺病

Exacerbations in Patients with Chronic Obstructive Pulmonary Disease Treated with Nebulized Glycopyrrolate versus Other Long-Acting Muscarinic Antagonists: A U.S. Healthcare Administrative Database Analysis

著录项

引文网络

相似文献

相关主题

期刊订阅